Evidence map›Paper›PMID 28743917›Full record

ArticleScientific reports2017

A rapid, low-cost, and microfluidic chip-based system for parallel identification of multiple pathogens related to clinical pneumonia.

Guoliang Huang, Qin Huang, Lan Xie, Guangxin Xiang, Lei Wang, Hui Xu, Li Ma, Xianbo Luo, Juan Xin, Xinying Zhou and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Rapid Detection ofJournal of microbiology and biotechnology · 2023
    Article
  10. Article
  11. Review
  12. Rapid, ultrasensitive and highly specific diagnosis ofFrontiers in cellular and infection microbiology · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guoliang HuangDepartment of Biomedical Engineering, the School of Medicine, Tsinghua University, Beijing, 100084, China. tshgl@tsinghua.edu.cn.
Qin HuangNational Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China.
Lan XieDepartment of Biomedical Engineering, the School of Medicine, Tsinghua University, Beijing, 100084, China.
Guangxin XiangNational Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China.
Lei WangNational Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China.
Hui XuNational Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China.
Li MaNational Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China.
Xianbo LuoNational Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China.
Juan XinNational Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China.
Xinying ZhouNational Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China.
Xiangyu JinDepartment of Biomedical Engineering, the School of Medicine, Tsinghua University, Beijing, 100084, China.
Lei ZhangNational Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China.

Funding

Analysis: Emotion-Based Alcohol Consumption with fMRI and Experimental ParadigmK01AA020102 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI CYDERS, MELISSA A · 2011 to 2015
$770k
NIAAA NIH HHS K01 AA020102
6 · The paper itself

Abstract

An air-insulated microfluidic chip was designed for the automatic centrifugal distribution of samples to 24-test cells, enabling the parallel identification of multiple clinical pneumonia-related pathogens in 1.45-μL reactions without cross-contamination in 45 min. A portable nucleic acid analyzer that integrates mechanical, confocal optical, electronic, and software functions was also developed to collect fluorescence data in a Ø3 mm imaging field near the optical diffraction limit for highly sensitive fluorescence detection of nucleic acid amplification in real time. This microfluidic chip-based portable nucleic acid analyzer could detect low abundance nucleic acids present at as few as 10 copies. In a blinded experiment, specific identification of Mycoplasma pneumoniae, Staphylococcus aureus, and methicillin-resistant S. aureus was achieved with 229 clinical patient sputum samples. The total coincidence rate of our system and traditional RT-PCR with an ABI 7500 was 99.56%. Four samples accounting for the 0.44% inconformity were retested by gene sequencing, revealing that our system reported the correct results. This novel microfluidic chip-based detection system is cost-effective, rapid, sensitive, specific, and has a relatively high throughput for parallel identification, which is especially suitable for resource-limited facilities/areas and point-of-care testing.

Indexed as

Lab-On-A-Chip DevicesAdolescentAdultBacteriological TechniquesEquipment DesignFemaleHumansLimit of DetectionMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedMolecular Diagnostic TechniquesMycoplasma pneumoniaeNucleic Acid Amplification TechniquesPneumonia, MycoplasmaPneumonia, Staphylococcal

Identifiers

PMID28743917
PMCPMC5527024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.